Evaxion ^{Publicly Traded Corporation}

Evaxion is an AI-driven biotech company that uses its proprietary AI-Immunology™ platform to identify vaccine targets across cancer and infectious diseases. Its clinical programs include a personalized cancer vaccine in Phase II, and preclinical candidates targeting Staphylococcus aureus, gonorrhea, CMV, and more.